marijuana stocks

Cara Therapeutics to Webcast Presentation at 22nd Annual NewsMakers in the Biotech Industry Conference

  Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 22nd Annual NewsMakers in the Biotech Industry Conference on Thursday, September 10, 2015, at 2:30 p.m. ET in New York City.

A live webcast of the presentation can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated efficacy in patients with moderate to severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

Contact:
INVESTOR CONTACT:
Jesse Baumgartner
Stern Investor Relations, Inc.
212-362-1200
Jesse@sternir.com
MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 Green Thumb Industries Inc. (GTBIF) to Open Rise Niles on May 28, Expands to Eight Cannabis Stores in Illinois

Green Thumb Industries to Open Rise Niles on May 28, Expands to…

Sundial Growers Inc. (SNDL) Announces Departure of CEO and other Leadership Changes

Sundial Announces Departure of CEO and other Leadership Changes and Optimization Initiatives…

Global Consortium, Inc. (GCGX) Continues to Build out America’s First Cannabis Mall

America’s first Cannabis Mall Distribution opening shortly Expanding footprint across California, expanding…

Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma’s (GTBP) Board of Directors

Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma’s Board…